High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study

dc.contributor.authorRequena-Méndez, Ana
dc.contributor.authorSalas-Coronas, Joaquín
dc.contributor.authorSalvador, Fernando
dc.contributor.authorGómez Junyent, Joan
dc.contributor.authorVillar Garcia, Judith
dc.contributor.authorSantín Cerezales, Miguel
dc.contributor.authorMuñoz, Carmen
dc.contributor.authorGonzález Cordón, Ana
dc.contributor.authorCabezas Fernández, Maria Teresa
dc.contributor.authorSulleiro, Elena
dc.contributor.authorArenas-Miras, Maria del Mar
dc.contributor.authorSomoza, Dolors
dc.contributor.authorVazquez Villegas, Jose
dc.contributor.authorTreviño, Begoña
dc.contributor.authorRodríguez de las Parras, Esperanza
dc.contributor.authorValls, M. Eugenia
dc.contributor.authorLlaberia Marcual, Jaume
dc.contributor.authorSubirà, Carme
dc.contributor.authorMuñoz, José
dc.date.accessioned2020-03-10T09:28:30Z
dc.date.available2020-03-10T09:28:30Z
dc.date.issued2020-02-11
dc.date.updated2020-02-21T19:02:03Z
dc.description.abstractIntroduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76–10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01–11.69), 9.22% (7.5–10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI −0.3–6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec699637
dc.identifier.issn2076-0817
dc.identifier.pmid32053864
dc.identifier.urihttps://hdl.handle.net/2445/152378
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.3390/pathogens9020107
dc.relation.ispartofPathogens, 2020, vol. 9, num. 2
dc.relation.urihttp://dx.doi.org/10.3390/pathogens9020107
dc.rightscc by (c) Requena-Méndez et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationNematodes
dc.subject.classificationMalalties parasitàries
dc.subject.otherNematodes
dc.subject.otherParasitic diseases
dc.titleHigh Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Requena-MendezA_Pathogens_2020.pdf
Mida:
729.85 KB
Format:
Adobe Portable Document Format